<DOC>
	<DOCNO>NCT00324051</DOCNO>
	<brief_summary>The purpose study estimate drug preference stable schizophrenic patient treat olanzapine orodispersible tablet 6 week olanzapine tablet 6 week vice-versa .</brief_summary>
	<brief_title>Patient 's Preference Between Conventional Oral Olanzapine Tablet v Olanzapine Orodispersible Tablet</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>You outpatient diagnose stable schizophrenia . You male female age 18 65 year old . You retrospectively judge investigator , base clinical interview impression , stable least 4 week . You must able take olanzapine orodispersible single daily dose . You treat conventional oral olanzapine tablet ( monotherapy ) least 1 month . You use olanzapine past long use bad reaction . You know Human immunodeficiency virus positive ( HIV+ ) status . You know uncorrected , narrow angle glaucoma . You know Leukopenia , ( abnormally low white blood cell count ) . You serious uncontrolled illness ( example : liver disease , history heart disease , inadequately control diabetes . ) You Parkinson 's disease . You female patient either pregnant nursing You take medication allow study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>